Finance

Beta
Lists
002653:SHE
Haisco Pharmaceutical Group Co Ltd
CNÂ¥47.58
-2.30%
(-1.12) 1D
Jun 5, 3:04:39 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002653...
Open
CNÂ¥49.34
High
CNÂ¥49.92
Low
CNÂ¥47.50
Mkt. cap
54.54B
Avg. vol.
5.18M
Volume
5.11M
Dividend
0.56%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
May 15, 2026
P/E ratio
69.42
52-wk high
CNÂ¥62.65
52-wk low
CNÂ¥40.70
EPS
CNÂ¥0.69
Shares outstanding
1.12B
No. of employees
6K
Open
CNÂ¥49.34
High
CNÂ¥49.92
Low
CNÂ¥47.50
Mkt. cap
54.54B
Avg. vol.
5.18M
Volume
5.11M
Dividend
0.56%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
May 15, 2026
P/E ratio
69.42
52-wk high
CNÂ¥62.65
52-wk low
CNÂ¥40.70
EPS
CNÂ¥0.69
Shares outstanding
1.12B
No. of employees
6K
News stories
From sources across the web
About Haisco Pharmaceutical Group Co Ltd
CEO-
Employees5.6K
Founded2000
Headquarters-
SectorPharmaceutical industry
Websitehaisco.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.11B
1.30B
1.09B
1.56B
Cost of goods sold
276.24M
320.07M
405.00M
290.96M
Cost of revenue
276.24M
320.07M
405.00M
290.96M
Research and development expenses
198.64M
200.61M
261.90M
225.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
511.73M
575.61M
590.48M
472.75M
Operating expense
721.10M
791.42M
859.43M
706.43M
Total operating expenses
997.34M
1.11B
1.26B
997.39M
Operating income
111.49M
187.81M
-176.78M
566.60M
Other non operating income
6.76M
-21.33M
23.71M
-2.33M
EBT including unusual items
89.51M
189.78M
-64.13M
592.93M
EBT excluding unusual items
116.30M
165.82M
-155.42M
565.01M
Income tax expense
7.30M
23.30M
-28.41M
38.33M
Effective tax rate
8.15%
12.28%
44.30%
6.46%
Other operating expenses
10.17M
12.38M
9.94M
10.01M
Net income
82.21M
166.48M
-35.72M
554.61M
Net profit margin
7.41%
12.81%
-3.28%
35.46%
Earnings per share
-
-
-
-
Interest and investment income
6.75M
7.04M
6.36M
7.50M
Interest expense
-8.34M
-8.05M
-7.63M
-6.76M
Net interest expenses
-1.58M
-1.01M
-1.27M
741.96K
Depreciation and amortization charges
-
-
-
-
EBITDA
172.62M
246.89M
-111.07M
632.30M
Gain or loss from assets sale
289.14K
-289.14K
22.27M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer